Trinity Biotech Stock Price, News & Analysis (NASDAQ:TRIB)

$5.63 -0.05 (-0.88 %)
(As of 12/18/2017 01:42 AM ET)
Previous Close$5.68
Today's Range$5.54 - $5.87
52-Week Range$4.22 - $7.27
Volume42,000 shs
Average Volume58,411 shs
Market Capitalization$135.35 million
P/E Ratio93.83
Dividend YieldN/A
Beta1.41

About Trinity Biotech (NASDAQ:TRIB)

Trinity Biotech logoTrinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the liver and intestine. It operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business. Trinity Biotech's blood bank screening business unit manufactures products to screen donated blood for transfusion-transmissible infections.

Receive TRIB News and Ratings via Email

Sign-up to receive the latest news and ratings for TRIB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diagnostic & Testing Substances Manufacturers
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:TRIB
CUSIPN/A
Phone353-1276-9800

Debt

Debt-to-Equity Ratio0.90%
Current Ratio5.16%
Quick Ratio3.77%

Price-To-Earnings

Trailing P/E Ratio93.83
Forward P/E Ratio93.83
P/E GrowthN/A

Sales & Book Value

Annual Sales$99.61 million
Price / Sales1.36
Cash Flow$0.47 per share
Price / Cash12.00
Book Value$4.52 per share
Price / Book1.25

Profitability

Trailing EPS($3.62)
Net Income$-100,620,000.00
Net Margins-100.00%
Return on Equity5.87%
Return on Assets2.57%

Miscellaneous

Employees582
Outstanding Shares24,040,000

Trinity Biotech (NASDAQ:TRIB) Frequently Asked Questions

What is Trinity Biotech's stock symbol?

Trinity Biotech trades on the NASDAQ under the ticker symbol "TRIB."

How were Trinity Biotech's earnings last quarter?

Trinity Biotech plc (NASDAQ:TRIB) issued its quarterly earnings results on Thursday, October, 26th. The company reported $0.06 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.03 by $0.03. The firm had revenue of $25.60 million for the quarter, compared to analyst estimates of $25.52 million. Trinity Biotech had a positive return on equity of 5.87% and a negative net margin of 100.00%. View Trinity Biotech's Earnings History.

When will Trinity Biotech make its next earnings announcement?

Trinity Biotech is scheduled to release their next quarterly earnings announcement on Tuesday, March, 13th 2018. View Earnings Estimates for Trinity Biotech.

Who are some of Trinity Biotech's key competitors?

Who are Trinity Biotech's key executives?

Trinity Biotech's management team includes the folowing people:

  • Ronan O'Caoimh, Executive Chairman of the Board (Age 57)
  • Kevin Tansley, Chief Financial Officer, Secretary (Age 42)
  • Rory Nealon, Chief Operating Officer, Executive Director
  • Eric Brouwer Ph.D., Chief Scientific Officer, and Vice President Cardiac
  • James Walsh Ph.D., Executive Director (Age 53)
  • Clinton H. Severson, Non-Executive Director (Age 69)
  • Denis R. Burger Ph.D., Senior Non-Executive Independent Director (Age 70)
  • Peter Coyne, Non-Executive Independent Director (Age 53)
  • James D. Merselis, Non-Executive Independent Director

Who owns Trinity Biotech stock?

Trinity Biotech's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Heartland Advisors Inc. (6.45%), Boston Partners (5.70%), Senvest Management LLC (3.71%), Russell Investments Group Ltd. (2.24%), Adirondack Research & Management Inc. (1.39%) and Stonepine Capital Management LLC (0.51%). View Institutional Ownership Trends for Trinity Biotech.

Who sold Trinity Biotech stock? Who is selling Trinity Biotech stock?

Trinity Biotech's stock was sold by a variety of institutional investors in the last quarter, including Stonepine Capital Management LLC, Heartland Advisors Inc. and JPMorgan Chase & Co.. View Insider Buying and Selling for Trinity Biotech.

Who bought Trinity Biotech stock? Who is buying Trinity Biotech stock?

Trinity Biotech's stock was acquired by a variety of institutional investors in the last quarter, including Senvest Management LLC, Russell Investments Group Ltd., Boston Partners and Adirondack Research & Management Inc.. View Insider Buying and Selling for Trinity Biotech.

How do I buy Trinity Biotech stock?

Shares of Trinity Biotech can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Trinity Biotech's stock price today?

One share of Trinity Biotech stock can currently be purchased for approximately $5.63.

How big of a company is Trinity Biotech?

Trinity Biotech has a market capitalization of $135.35 million and generates $99.61 million in revenue each year. The company earns $-100,620,000.00 in net income (profit) each year or ($3.62) on an earnings per share basis. Trinity Biotech employs 582 workers across the globe.

How can I contact Trinity Biotech?

Trinity Biotech's mailing address is IDA BUSINESS PARK BRAY, WICKLOW L2, . The company can be reached via phone at 353-1276-9800 or via email at [email protected]


MarketBeat Community Rating for Trinity Biotech (TRIB)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  82 (Vote Outperform)
Underperform Votes:  109 (Vote Underperform)
Total Votes:  191
MarketBeat's community ratings are surveys of what our community members think about Trinity Biotech and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Trinity Biotech (NASDAQ:TRIB) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldBuyBuy
Consensus Rating Score: 2.002.002.502.50
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Trinity Biotech (NASDAQ:TRIB) Consensus Price Target History

Price Target History for Trinity Biotech (NASDAQ:TRIB)

Trinity Biotech (NASDAQ:TRIB) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/5/2016StephensDowngradeOverweight -> Equal WeightN/AView Rating Details
4/21/2016Roth CapitalReiterated RatingBuyN/AView Rating Details
(Data available from 12/18/2015 forward)

Earnings

Trinity Biotech (NASDAQ:TRIB) Earnings History and Estimates Chart

Earnings by Quarter for Trinity Biotech (NASDAQ:TRIB)

Trinity Biotech (NASDAQ TRIB) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/12/2018$0.07N/AView Earnings Details
10/26/20179/30/2017$0.03$0.06$25.52 million$25.60 millionViewN/AView Earnings Details
7/20/20176/30/2017$0.06$0.03$24.83 million$25.45 millionViewN/AView Earnings Details
4/27/20173/31/2017$0.03$0.01$24.24 million$23.54 millionViewN/AView Earnings Details
10/25/2016Q3$0.07$0.07$26.50 million$26.10 millionViewListenView Earnings Details
7/21/2016Q2$0.06$0.09$24.30 million$26.30 millionViewListenView Earnings Details
4/19/2016Q1$0.08$0.06$24.34 million$23.52 millionViewListenView Earnings Details
3/3/2016Q4$0.09$0.29$251.00 million$271.20 millionViewN/AView Earnings Details
10/22/2015Q3$0.09$0.10$25.40 million$27.20 millionViewListenView Earnings Details
7/28/2015Q2$0.14$0.07$26.09 million$24.26 millionViewListenView Earnings Details
4/30/2015Q115$0.17$0.17$25.93 million$25.20 millionViewN/AView Earnings Details
3/3/2015Q414$0.18$0.18$27.30 million$26.70 millionViewN/AView Earnings Details
10/23/2014Q114$0.20$0.19$27.30 million$27.20 millionViewListenView Earnings Details
7/29/2014Q413$0.20$0.18$27.00 million$26.00 millionViewN/AView Earnings Details
4/29/2014$0.19$0.18$25.48 million$25.03 millionViewN/AView Earnings Details
3/4/2014Q4$0.21$0.20ViewN/AView Earnings Details
10/17/2013Q313$0.21$0.21$24.68 million$24.10 millionViewN/AView Earnings Details
7/30/2013Q2 2013$0.20$0.21$22.03 million$21.30 millionViewN/AView Earnings Details
3/5/2013Q4 2012$0.21$0.20$21.84 million$20.80 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Trinity Biotech (NASDAQ:TRIB) Earnings Estimates

2017 EPS Consensus Estimate: $0.26
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.04$0.04$0.04
Q2 20171$0.06$0.06$0.06
Q3 20171$0.08$0.08$0.08
Q4 20171$0.08$0.08$0.08
(Data provided by Zacks Investment Research)

Dividends

Trinity Biotech (NASDAQ:TRIB) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/23/2014annual$0.223.72%6/6/20146/10/20147/1/2014
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Trinity Biotech (NASDAQ TRIB)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Trinity Biotech (NASDAQ TRIB) News Headlines

Source:
DateHeadline
Trinity Biotech Plc: Gathering momentum, but may lack supportTrinity Biotech Plc: Gathering momentum, but may lack support
finance.yahoo.com - December 12 at 3:43 PM
Zacks Investment Research Lowers Trinity Biotech PLC (TRIB) to Strong SellZacks Investment Research Lowers Trinity Biotech PLC (TRIB) to Strong Sell
www.americanbankingnews.com - November 1 at 11:56 AM
Trinity Biotech Plc :TRIB-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017Trinity Biotech Plc :TRIB-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017
finance.yahoo.com - November 1 at 9:49 AM
Edited Transcript of TRIB earnings conference call or presentation 26-Oct-17 3:00pm GMTEdited Transcript of TRIB earnings conference call or presentation 26-Oct-17 3:00pm GMT
finance.yahoo.com - October 27 at 7:02 AM
Trinity Biotech PLC (TRIB) Announces Quarterly  Earnings ResultsTrinity Biotech PLC (TRIB) Announces Quarterly Earnings Results
www.americanbankingnews.com - October 26 at 9:06 PM
Trinity Biotech Announces Results for Q3, 2017Trinity Biotech Announces Results for Q3, 2017
finance.yahoo.com - October 26 at 9:34 AM
Trinity Biotech Plc Sponsored ADR Class A to Host Earnings CallTrinity Biotech Plc Sponsored ADR Class A to Host Earnings Call
finance.yahoo.com - October 26 at 9:34 AM
Trinity Biotech PLC (TRIB) Scheduled to Post Earnings on MondayTrinity Biotech PLC (TRIB) Scheduled to Post Earnings on Monday
www.americanbankingnews.com - October 16 at 3:50 AM
Trinity Biotech plc to Announce 2017 Third Quarter Financial ResultsTrinity Biotech plc to Announce 2017 Third Quarter Financial Results
feeds.benzinga.com - October 13 at 5:19 AM
INVESTOR ALERT: Kirby McInerney LLP Commences Investigation on Behalf of Trinity Biotech plc InvestorsINVESTOR ALERT: Kirby McInerney LLP Commences Investigation on Behalf of Trinity Biotech plc Investors
finance.yahoo.com - August 11 at 8:57 AM
Trinity Biotech Plc :TRIB-US: Earnings Analysis: Q2, 2017 By the Numbers : July 26, 2017Trinity Biotech Plc :TRIB-US: Earnings Analysis: Q2, 2017 By the Numbers : July 26, 2017
finance.yahoo.com - July 27 at 8:37 AM
Trinity Biotech PLC (TRIB) Issues Quarterly  Earnings ResultsTrinity Biotech PLC (TRIB) Issues Quarterly Earnings Results
www.americanbankingnews.com - July 21 at 11:05 AM
Investor Network: Trinity Biotech Plc Sponsored ADR to Host Earnings CallInvestor Network: Trinity Biotech Plc Sponsored ADR to Host Earnings Call
www.baystreet.ca - July 21 at 8:01 AM
Investor Network: Trinity Biotech Plc Sponsored ADR to Host Earnings CallInvestor Network: Trinity Biotech Plc Sponsored ADR to Host Earnings Call
www.baystreet.ca - July 21 at 8:01 AM
Edited Transcript of TRIB earnings conference call or presentation 20-Jul-17 3:00pm GMTEdited Transcript of TRIB earnings conference call or presentation 20-Jul-17 3:00pm GMT
finance.yahoo.com - July 21 at 8:01 AM
Edited Transcript of TRIB earnings conference call or presentation 20-Jul-17 3:00pm GMTEdited Transcript of TRIB earnings conference call or presentation 20-Jul-17 3:00pm GMT
finance.yahoo.com - July 21 at 8:01 AM
Head-To-Head Survey: Trinity Biotech PLC (TRIB) & DBV Technologies (DBVT)Head-To-Head Survey: Trinity Biotech PLC (TRIB) & DBV Technologies (DBVT)
www.americanbankingnews.com - July 20 at 9:16 AM
Trinity Biotech PLC (NASDAQ:TRIB) vs. DBV Technologies (DBVT) Head-To-Head SurveyTrinity Biotech PLC (NASDAQ:TRIB) vs. DBV Technologies (DBVT) Head-To-Head Survey
www.americanbankingnews.com - July 20 at 9:15 AM
Trinity Biotech Announces Results for Q2, 2017Trinity Biotech Announces Results for Q2, 2017
finance.yahoo.com - July 20 at 8:51 AM
Contrasting Trinity Biotech PLC (TRIB) & DBV Technologies (DBVT)Contrasting Trinity Biotech PLC (TRIB) & DBV Technologies (DBVT)
www.americanbankingnews.com - July 18 at 12:27 AM
Trinity Biotech PLC (TRIB) Set to Announce Earnings on ThursdayTrinity Biotech PLC (TRIB) Set to Announce Earnings on Thursday
www.americanbankingnews.com - July 13 at 10:08 PM
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2017 Financial ResultsTrinity Biotech plc to Announce Second Quarter Fiscal Year 2017 Financial Results
finance.yahoo.com - July 4 at 8:10 AM
Trinity Biotech plc to Announce Second Quarter  Fiscal Year 2017 Financial ResultsTrinity Biotech plc to Announce Second Quarter Fiscal Year 2017 Financial Results
feeds.benzinga.com - July 3 at 8:29 AM
Form F-3/A TRINITY BIOTECH PLCForm F-3/A TRINITY BIOTECH PLC
www.streetinsider.com - April 26 at 4:46 PM
Trinity Biotech plc to Announce First Quarter Fiscal Year 2017 Financial ResultsTrinity Biotech plc to Announce First Quarter Fiscal Year 2017 Financial Results
feeds.benzinga.com - April 18 at 7:40 AM
BRIEF-Trinity Biotech quarterly EPS $0.043BRIEF-Trinity Biotech quarterly EPS $0.043
www.reuters.com - March 14 at 7:50 PM
Q4 2016 Trinity Biotech PLC Earnings Release - Time Not SuppliedQ4 2016 Trinity Biotech PLC Earnings Release - Time Not Supplied
biz.yahoo.com - March 14 at 8:56 AM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Trinity Biotech plc (TRIB) - PR Newswire (press release)SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Trinity Biotech plc (TRIB) - PR Newswire (press release)
www.prnewswire.com - March 2 at 12:05 AM
Trinity Biotech plc to Announce Fourth Quarter  and Fiscal Year 2016 Financial ResultsTrinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2016 Financial Results
feeds.benzinga.com - February 24 at 8:13 AM
Immunoassay Markets: Global Analysis and Opportunity Evaluation 2016 - 2020Immunoassay Markets: Global Analysis and Opportunity Evaluation 2016 - 2020
www.marketwatch.com - January 24 at 12:17 AM
Bragar Eagel & Squire, P.C. Is Investigating Trinity Biotech plc (TRIB) on Behalf of Stockholders and Encourages ... - Business Wire (press release)Bragar Eagel & Squire, P.C. Is Investigating Trinity Biotech plc (TRIB) on Behalf of Stockholders and Encourages ... - Business Wire (press release)
www.businesswire.com - January 7 at 6:07 AM
Form 6-K TRINITY BIOTECH PLC For: Dec 01Form 6-K TRINITY BIOTECH PLC For: Dec 01
www.streetinsider.com - December 19 at 8:54 AM

SEC Filings

Trinity Biotech (NASDAQ:TRIB) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Trinity Biotech (NASDAQ:TRIB) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Trinity Biotech (NASDAQ TRIB) Stock Chart for Monday, December, 18, 2017

Loading chart…

This page was last updated on 12/18/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.